The effects of different levels of oocyst inocula of Eimeria acervulina, E. tenella, or E. maxima on plasma carotenoids, total plasma lipids, total plasma proteins, packed cell volume (PCV), bird performance, and coccidial lesion scores were determined in male Hubbard chickens. Each test consisted of an uninfected treatment and either four levels (E. tenella and E. maxima) or five levels (E. acervulina) of inocula. Carotenoids and lipids were significantly (P < or = 0.05) depressed by E. acervulina starting at 10(2) oocysts per bird, whereas 10(4) and higher inoculum levels significantly depressed plasma protein. Carotenoids and lipids were significantly depressed by E. tenella beginning at 10(4) oocysts per bird, whereas 10(2) oocysts per bird and greater levels significantly depressed plasma protein. E. maxima significantly depressed carotenoids and lipids beginning at 6.7 x 10(2) oocysts per bird and plasma protein at 6.7 x 10(4) oocysts per bird. PCV was depressed by E. acervulina and E. tenella starting at 10(4) oocysts per bird but was not affected by E. maxima. Weight gain was significantly depressed by E. acervulina beginning at 10(5) oocysts per bird, by E. tenella at 10(4) oocysts per bird, and by E. maxima at 6.7 x 10(4) oocysts per bird. Coefficients of determination (R2) were highest for carotenoids (0.96-0.99), followed by lipids (0.93-0.96), weight gain (0.89-0.91), feed:weight gain ratio (0.89-0.91), and protein and PCV (0.65-0.92). Results demonstrated that plasma carotenoids and lipids were excellent response variables for measuring the effects on broiler chickens of each of the Eimeria spp. tested.
The relationship between oocyst dose and lesion score was evaluated in trials involving five field isolates each of Eimeria acervulina, Eimeria maxima, and Eimeria tenella. Each trial included an uninfected, unmedicated treatment, and at least three treatments of unmedicated birds given different doses of oocysts from a single isolate. In four trials each with E. acervulina and E. tenella, and all five trials with E. maxima, infected, salinomycin-medicated (60 ppm) treatments were included. Each treatment consisted of five cages with eight male broiler birds per cage using a randomized complete block design. The relationship between oocyst dose and lesion score was examined within each coccidial species using the linear model: Y = beta0 + beta1(log(n) oocyst dose + 1). The results demonstrated that in unmedicated birds, low oocyst doses caused mean lesion scores up to 2.0, but the numbers required to cause higher mean scores were many times greater. Second, the estimated oocyst dose in salinomycin-medicated birds for any given mean lesion score was substantially more than the corresponding estimate for unmedicated birds. These results indicated that there could be wide differences in levels of oocyst dose between unmedicated and medicated birds that lesion scores failed to measure. If lesion scores are used in trials comparing anticoccidial drugs, an alternative design may be to include three infected, unmedicated treatments each given a different level of inoculum (e.g., low, medium, and high). Medicated treatments, given the highest oocyst dose only, would then be compared to each of the infected, unmedicated treatments.
SUMMARYA relationship was estimated between weight gains and coccidial lesion scores measured on individual male broiler chicks experimentally infected with different field isolates of Eimeria acervulina (seven tests), E. maxima (five tests) or E. tenella (eight tests). There was a small decrease in weight gain as lesion scores increased in E. acervulina infections, and a modest reduction in weight gain with increasing lesion scores in E. maxima and E. tenella infections. This relationship was observed in both nonmedicated birds and birds fed on dicts containing 60 mg salinomycin/kg. The weight gains for birds fed 60 mg/kg with lesion scores of 2, 3 and 4 for E. acervulina. 1,2,3 and 4 for E. maxima and 2 and 3 for E. tenella were significantly greater than the weight gains of nonmedicated birds with the same lesion scores. The results demonstrated that lesion scoring does not fully reflect the degree of disease severity in induced infection. High lesion scores caused by the three species studied were associated with small changes in weight gain in medicated birds when compared with nonmedicated birds.
Two 42-d floor pen studies were conducted with commercial broiler chickens to measure the efficacy of 1 ppm diclazuril in the starter or grower diet in shuttle programs with 66 ppm salinomycin. Study 1 compared a salinomycin to diclazuril (starter to grower diet) shuttle treatment with salinomycin to salinomycin, salinomycin to 100 ppm monensin, salinomycin to 99.8 ppm lasalocid, and unmedicated treatments. Study 2 compared a diclazuril to salinomycin (starter to grower) shuttle treatment with 125 ppm nicarbazin to salinomycin, 79.2 ppm narasin + nicarbazin to salinomycin, 125 ppm zoalene to salinomycin, and unmedicated treatments. Fifty 1-d-old chicks were randomly allotted to each of 10 pens per treatment in each study using a randomized complete block design. Starter (Days 0 to 21) and grower (Days 22 to 37) diets in each study contained 55 ppm bacitracin methylene disalicylate. The finisher diet (Days 38 to 42) in each study was unmedicated. Birds were inoculated via their feed on Day 22 (Study 1) or Day 15 (Study 2) with a mixed inoculum of Eimeria acervulina, Eimeria maxima, and Eimeria tenella. Four birds per pen (two male and two female) were randomly selected in each study for coccidial lesion scores on Day 6 postinoculation. These studies demonstrated that the use of 1 ppm diclazuril in shuttle programs was highly efficacious against a mixed inoculum of Eimeria spp. in comparison with nicarbazin, narasin + nicarbazin, and zoalene in starter diets and salinomycin, monensin, and lasalocid in grower diets.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.